Clinicopathologic features and prognostic factors of malignant phyllodes tumors

Objective To study the clinicopathologic features of malignant phyllodes tumors (PT)by histopathologic analyses,immunohistochemical profiling and DNA content assay,and evaluation of the clinical outcome.Methods Ten patients with malignant PT from 1999 to 2013 who were treated by surgery were enrolled in this study.The morphologic characteristics were studied under light microscope,standard two-step EnVision method of immunohistochemical staining was used to assess the expression of CK5/6,CKpan,34β3E12,desmin,p63,ER-α,PR,Ki-67,CD34,SMA,p53,p16,bcl-2 and CD117 in the tumors.The corresponding paraffin blocks were also used for flow cytometric DNA content assay.These data were correlated with the follow-up results.Results The median age of onset was 46.5 years old.The mean tumor size was 7.4 cm (2.0-25.0 cm).At the end of the follow-up period (22 to 125 months),there were tumor recurrences in 3/8 patients and the median time of recurrence was 24 months.Metastasis occurred in 3/8 patients who all died of the tumors.PT had heterogeneous histology,with stromal overgrowth with leaf-like projections,periductal stromal overgrowth,and most commonly,diffuse stromal overgrowth with sarcomatous differentiation.The mean positive index of Ki-67 was 11.4％.The stromal tumor cells were positive for CD34,SMA,p53,p16,and bcl-2 in 3/10,9/10,6/10,8/10,and 4/10 cases,respectively.CD117,ER-α and PR were negative.Interpretable DNA histograms were obtained in nine cases with triploidy in two cases.Conclusions The diagnosis of malignant PT should be considered based on the diversity of growth patterns and heterogeneous histology.Ki-67 and CD34 are valuable diagnostic and prognostic factors in patients with malignant PT.Tumors with diffuse stromal overgrowth,heterologous elements,Ki-67 ≥20％ or aneuploidy are more likely to metastasize. Key words: Breast neoplasms ;  Phyllodes tumor;  Pathology, clinical;  Immunohistochemistry